Search Results 31-40 of 999 for 2024vadodara

  1. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Minimally Invasive Surgery Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the impact of image resolution and 3D imaging on cognitive load (i.e. NASA-TLX) and laparoscopic skill performance in a ...

  3. Behavior of Valve Leaflets - Mayo Clinic

    This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients ...

  4. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection - Mayo Clinic

    The purpose of this study is to investigate the effectiveness and safety of Rivaroxaban for reducing the risk of major venous and arterial thrombotic events, ...

  5. Mayo Clinic Q&A - Dr. Abinash Virk - gender, equity and COVI...

    Dr. Abinash Virk 00:01. Coming up on Mayo Clinic Q&A, race is more impacted in terms of diagnosis and treatment of. COVID-19 than gender is.

  6. Cardiovascular Surgery - News from Mayo Clinic

    2024. Genetic testing pinpoints cardiovascular risk in patients with aortic disorders Feb. 07, 2024, 03:30 p.m. CDT. 2023.

  7. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  8. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  9. Early Detection Initiative for Pancreatic Cancer (EDI) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, work in different ways to stop the growth of tumor cells, either ...